India to United States: Emtricitabine Export Trade Route
India has recorded 149 verified shipments of Emtricitabine exported to United States, representing a combined trade value of $11.8M USD. This corridor is served by 19 active Indian exporters, with an average shipment value of $79.0K USD. The leading Indian exporter is AUROBINDO PHARMA LTD, which accounts for 27% of total export value with 27 shipments worth $3.1M USD. On the buying side, AUROLOGISTICS LLC (AUROBINDO PHARMA is the largest importer in United States with $1.9M USD in purchases. The top 3 suppliers — AUROBINDO PHARMA LTD, AUROBINDO PHARMA LIMITED, MACLEODS PHARMACEUTICALS LTD — together control 66% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Emtricitabine corridor is one of India's established pharmaceutical export routes, with 149 shipments documented worth a combined $11.8M USD. The route is dominated by AUROBINDO PHARMA LTD, which alone accounts for roughly 27% of all export value, reflecting the consolidated nature of India's emtricitabine manufacturing sector.
Across 19 active suppliers, the average shipment value stands at $79.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 83% of all shipments, consistent with emtricitabine's non-urgent bulk-order profile.
Shipment activity peaks during July–September, with an average transit time of 20 days port-to-port. The route has recorded an annual growth rate of 21.6%, placing it at rank #3 among India's top emtricitabine export destinations globally.
On the import side, key buyers of Indian emtricitabine in United States include AUROLOGISTICS LLC (AUROBINDO PHARMA, AUROLOGISTICS LLC AUROBINDO PHARM, NORTHSTAR DISTRIBUTION CENTER 8912 and 31 others. AUROLOGISTICS LLC (AUROBINDO PHARMA is the single largest importer with 13 shipments valued at $1.9M USD.
Route Characteristics
- Average transit20 days
- Peak seasonQ3
- Primary modeSea freight
- Top portJNPT
Market Position
- Global rank#3
- Annual growth+21.6%
- Demand growth+18.4%
- Regulatory ease87/100
Top 10 Indian Emtricitabine Exporters to United States
Showing top 10 of 19 Indian suppliers exporting Emtricitabine to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | AUROBINDO PHARMA LTD Avg $116.5K per shipment | 27 | $3.1M | 26.7% |
| 2 | AUROBINDO PHARMA LIMITED Avg $186.2K per shipment | 16 | $3.0M | 25.3% |
| 3 | MACLEODS PHARMACEUTICALS LTD Avg $40.0K per shipment | 40 | $1.6M | 13.6% |
| 4 | CIPLA LIMITED Avg $482.0K per shipment | 2 | $964.0K | 8.2% |
| 5 | MACLEODS PHARMACEUTICALS LIMITED Avg $36.0K per shipment | 26 | $936.5K | 8.0% |
| 6 | MYLAN LABORATORIES LIMITED Avg $74.1K per shipment | 10 | $741.2K | 6.3% |
| 7 | HETERO LABS LIMITED Avg $191.0K per shipment | 3 | $573.1K | 4.9% |
| 8 | ZYDUS LIFESCIENCES LIMITED Avg $140.3K per shipment | 2 | $280.6K | 2.4% |
| 9 | ANNORA PHARMA PRIVATE LIMITED Avg $17.4K per shipment | 12 | $208.6K | 1.8% |
| 10 | LAURUS LABS LIMITED Avg $52.0K per shipment | 2 | $104.0K | 0.9% |
This table shows the top 10 of 19 Indian companies exporting emtricitabine to United States, ranked by total trade value. The listed exporters are: AUROBINDO PHARMA LTD, AUROBINDO PHARMA LIMITED, MACLEODS PHARMACEUTICALS LTD, CIPLA LIMITED, MACLEODS PHARMACEUTICALS LIMITED, MYLAN LABORATORIES LIMITED, HETERO LABS LIMITED, ZYDUS LIFESCIENCES LIMITED, ANNORA PHARMA PRIVATE LIMITED, LAURUS LABS LIMITED. AUROBINDO PHARMA LTD is the dominant supplier with 27 shipments worth $3.1M USD, giving it a 27% market share. The top 3 suppliers together account for 66% of the total trade value on this route.
Showing top 10 of 19 total Indian exporters on the India to United States Emtricitabine export route.
Top 10 Emtricitabine Importers in United States
Showing top 10 of 34 known buyers in United States receiving Emtricitabine shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian emtricitabine in United States include AUROLOGISTICS LLC (AUROBINDO PHARMA, AUROLOGISTICS LLC AUROBINDO PHARM, NORTHSTAR DISTRIBUTION CENTER 8912, AUROLOGISTICS LLC, CIPLA USA INC UPS SUPPLY CHAIN SOLU, among 34 total buyers. The largest importer is AUROLOGISTICS LLC (AUROBINDO PHARMA, accounting for $1.9M USD across 13 shipments — representing 16% of all emtricitabine imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | AUROLOGISTICS LLC (AUROBINDO PHARMA | 13 | $1.9M | 16.5% |
| 2 | AUROLOGISTICS LLC AUROBINDO PHARM | 6 | $1.4M | 11.7% |
| 3 | NORTHSTAR DISTRIBUTION CENTER 8912 | 38 | $1.3M | 10.9% |
| 4 | AUROLOGISTICS LLC | 8 | $988.8K | 8.4% |
| 5 | CIPLA USA INC UPS SUPPLY CHAIN SOLU | 2 | $964.0K | 8.2% |
| 6 | TO THE ORDER OF | 8 | $713.2K | 6.1% |
| 7 | MACLEODS PHARMA USA INC | 13 | $584.5K | 5.0% |
| 8 | AUROBINDO PHARMA USA INC AUROLOG | 1 | $568.9K | 4.8% |
| 9 | MYLAN PHARMACEUTICALS INC | 7 | $460.4K | 3.9% |
| 10 | QUALLENT PHARMACEUTICALS HEALTH LLC | 6 | $417.1K | 3.5% |
Showing top 10 of 34 Emtricitabine importers in United States on this route.
Top 10 Emtricitabine Formulations Imported by United States
Showing top 10 of 87 product formulations shipped on the India to United States Emtricitabine route, ranked by trade value
United States imports a wide range of emtricitabine formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — EMTRICITABINE 200MG/ TENOFOVIR DISOPROXIL FUMARATE 300MG TABLETS 30'S(EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE — accounts for $754.4K USD across 3 shipments. There are 87 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | EMTRICITABINE 200MG/ TENOFOVIR DISOPROXIL FUMARATE 300MG TABLETS 30'S(EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 3 | $754.4K | 6.4% |
| 2 | TENOFOVIR DISOPROXIL FUMARATE + EMTRICITABINE | 3 | $573.1K | 4.9% |
| 3 | EMTRICITABINE CAPSULES 200 MG Emtricitabine Capsules 200mg 8736X30 S | 1 | $568.9K | 4.8% |
| 4 | EMTRICITABINE CAPSULES 200MG NDC No. 6 | 1 | $487.3K | 4.1% |
| 5 | EMTRICITABINE CAPSULES 200MG NDC No 69097 642 02 ANDA No 091168 1 X 30S X 4584 PACK 137520 NUM | 1 | $476.7K | 4.1% |
| 6 | DRUGS AND PHARMACEUTICALS HARMLESS MEDICINES EMTRICITABINE 200MG + TENOFOVIR DISOPROXIL FUMARATE 300MG TABLETSNOS | 15 | $445.3K | 3.8% |
| 7 | EMTRICITABINE 200MG/ TENOFOVIR DISOPROXIL FUMARATE 300MG TABLETS 77568X30'S | 1 | $429.1K | 3.6% |
| 8 | EMTRICITABINE CAPSULES 200 MG (EMTRICITABINE CAPSULES 200MG) 30'SNOS | 3 | $410.3K | 3.5% |
| 9 | EMTRICITABINE 200MG/ TENOFOVIR DISOPROXI | 4 | $348.9K | 3.0% |
| 10 | EMTRICITABINE CAPSULES 200MG (4944 X 30S PACK) | 1 | $325.7K | 2.8% |
Showing top 10 of 87 Emtricitabine formulations imported by United States on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 83%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
JNPT handles the highest volume with 22 shipments. Transit time averages 20 days by sea.
Market Dynamics
India's emtricitabine exports to United States are driven primarily by a handful of large-scale manufacturers. AUROBINDO PHARMA LTD with 27 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 19 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — AUROBINDO PHARMA LTD, AUROBINDO PHARMA LIMITED, MACLEODS PHARMACEUTICALS LTD — together account for 66% of total trade value on this route. The average shipment value of $79.0K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as tenofovir disoproxil fumarate + emtricitabine and emtricitabine capsules 200 mg emtricitabine capsules 200mg 8736x30 s, suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, AUROLOGISTICS LLC (AUROBINDO PHARMA is the largest importer with 13 shipments worth $1.9M USD — representing 16% of all emtricitabine imports from India on this route. A total of 34 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $11.8M
- Avg. Shipment
- $79.0K
- Suppliers
- 19
- Buyers
- 34
- Transit (Sea)
- ~20 days
- Annual Growth
- +21.6%
Related Analysis
Reverse Direction
United States → India — Emtricitabine (Import)Other Emtricitabine Routes
Unlock the Full India to United States Emtricitabine Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 149 shipments on this route.
Frequently Asked Questions — India to United States Emtricitabine Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Emtricitabine to United States?
The leading Indian exporters of Emtricitabine to United States are AUROBINDO PHARMA LTD, AUROBINDO PHARMA LIMITED, MACLEODS PHARMACEUTICALS LTD. AUROBINDO PHARMA LTD holds the largest market share at approximately 27% of total trade value on this route.
Q What is the total value of Emtricitabine exports from India to United States?
India exports Emtricitabine to United States worth approximately $11.8M USD across 149 recorded shipments. The average value per shipment is $79.0K USD.
Q Which ports does India use to ship Emtricitabine to United States?
The most active port of origin is JNPT with 22 shipments. Indian exporters primarily use sea freight for this route, with 83% of shipments going by sea and 28% by air.
Q How long does shipping take from India to United States for Emtricitabine?
The average transit time for Emtricitabine shipments from India to United States is approximately 20 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during July–September.
Q Is the India to United States Emtricitabine trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 21.6% with demand growth tracking at 18.4%. The route is ranked #3 among India's top Emtricitabine export destinations globally.
Q How many suppliers are active on the India to United States Emtricitabine route?
There are currently 19 active Indian suppliers exporting Emtricitabine to United States. The market is moderately concentrated with AUROBINDO PHARMA LTD accounting for 27% of total shipment value.
Q Who are the main importers of Emtricitabine from India in United States?
The leading importers of Indian Emtricitabine in United States include AUROLOGISTICS LLC (AUROBINDO PHARMA, AUROLOGISTICS LLC AUROBINDO PHARM, NORTHSTAR DISTRIBUTION CENTER 8912, AUROLOGISTICS LLC, CIPLA USA INC UPS SUPPLY CHAIN SOLU. AUROLOGISTICS LLC (AUROBINDO PHARMA is the largest buyer with 13 shipments worth $1.9M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Emtricitabine.
- 2.Supplier/Buyer Matching: 19 Indian exporters and 34 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 149 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
149 Verified Shipments
19 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists